An indirect ELISA was used to measure the amount of EAD IgM/IgG/IgA in plasma samples from 77 RA patients, 28 SLE patients (disease controls), and 28 HCs (Figure 1(a)). This evidence concerns the gene CD79A and systemic lupus erythematosus.